tiprankstipranks
Trending News
More News >
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market

Quince Therapeutics (QNCX) Income Statement

Compare
922 Followers

Quince Therapeutics Income Statement

Last quarter (Q3 2025), Quince Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Quince Therapeutics's net income was $-13.44M. See Quince Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -344.00K$ 0.00
Operating Expenses
$ 57.28M$ 34.62M$ 52.02M$ 90.32M$ 78.89M
Depreciation and Amortization
$ 186.00K$ 322.00K$ 204.00K$ 344.00K$ 332.00K
EBITDA
$ -35.98M$ -26.82M$ -50.99M$ -89.97M$ -78.56M
Operating Income
$ -57.28M$ -34.62M$ -52.02M$ -90.32M$ -78.89M
Other Income/Expenses
$ 544.00K$ 3.04M$ 71.00K$ 373.00K$ 2.04M
Pretax Income
$ -56.74M$ -31.58M$ -51.94M$ -89.94M$ -76.85M
Net Income
$ -56.83M$ -31.39M$ -51.66M$ -89.94M$ -76.85M
Per Share Metrics
Basic EPS
$ -1.31$ -0.84$ -1.54$ -3.03$ -2.63
Diluted EPS
$ -1.31$ -0.84$ -1.54$ -3.03$ -2.63
Weighted Average Shares Outstanding
43.26M 37.24M 33.50M 29.72M 29.18M
Weighted Average Shares Outstanding (Diluted)
43.26M 37.24M 33.50M 29.72M 29.18M
Currency in USD

Quince Therapeutics Earnings and Revenue History